# Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

> **NCT00210301** · NA · UNKNOWN · sponsor: **Institute for Clinical Research** · enrollment: 60 (—)

## Conditions studied

- Relapsing-Remitting Multiple Sclerosis

## Interventions

- **DRUG:** Provigil (modafinil)

## Key facts

- **NCT ID:** NCT00210301
- **Lead sponsor:** Institute for Clinical Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210301, "Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00210301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*